Janney Montgomery Scott LLC Has $990,000 Stake in Doximity, Inc. (NASDAQ:DOCS)

Janney Montgomery Scott LLC lessened its stake in Doximity, Inc. (NASDAQ:DOCS) by 3.5% during the fourth quarter, Holdings Channel reports. The firm owned 18,547 shares of the company’s stock after selling 678 shares during the period. Janney Montgomery Scott LLC’s holdings in Doximity were worth $990,000 as of its most recent SEC filing.

Other hedge funds also recently modified their holdings of the company. FMR LLC lifted its stake in Doximity by 30.5% during the 3rd quarter. FMR LLC now owns 6,837,733 shares of the company’s stock valued at $297,920,000 after acquiring an additional 1,598,602 shares in the last quarter. State Street Corp raised its holdings in shares of Doximity by 2.5% in the third quarter. State Street Corp now owns 3,693,982 shares of the company’s stock valued at $160,947,000 after purchasing an additional 88,922 shares during the last quarter. Geode Capital Management LLC lifted its position in shares of Doximity by 19.8% during the third quarter. Geode Capital Management LLC now owns 2,856,984 shares of the company’s stock valued at $124,503,000 after purchasing an additional 472,565 shares in the last quarter. Charles Schwab Investment Management Inc. boosted its holdings in Doximity by 4.4% during the third quarter. Charles Schwab Investment Management Inc. now owns 753,001 shares of the company’s stock worth $32,808,000 after purchasing an additional 31,966 shares during the last quarter. Finally, Lord Abbett & CO. LLC bought a new stake in Doximity in the 3rd quarter worth about $29,453,000. Hedge funds and other institutional investors own 87.19% of the company’s stock.

Doximity Stock Performance

NASDAQ:DOCS opened at $58.14 on Thursday. Doximity, Inc. has a 52-week low of $22.96 and a 52-week high of $61.75. The business’s fifty day moving average is $54.98 and its 200 day moving average is $45.22. The firm has a market cap of $10.85 billion, a price-to-earnings ratio of 66.82, a PEG ratio of 4.68 and a beta of 1.39.

Doximity (NASDAQ:DOCS) last announced its quarterly earnings results on Thursday, November 7th. The company reported $0.24 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.26 by ($0.02). The firm had revenue of $136.83 million during the quarter, compared to analysts’ expectations of $127.05 million. Doximity had a return on equity of 19.79% and a net margin of 33.69%. During the same period in the previous year, the company posted $0.18 earnings per share. Equities analysts predict that Doximity, Inc. will post 0.88 EPS for the current fiscal year.

Insider Buying and Selling

In other news, Director Timothy S. Cabral sold 20,000 shares of Doximity stock in a transaction dated Monday, February 3rd. The stock was sold at an average price of $57.62, for a total transaction of $1,152,400.00. Following the completion of the sale, the director now owns 6,360 shares in the company, valued at approximately $366,463.20. This trade represents a 75.87 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. 37.40% of the stock is currently owned by insiders.

Analyst Ratings Changes

Several equities analysts have commented on DOCS shares. The Goldman Sachs Group began coverage on shares of Doximity in a research report on Friday, November 15th. They set a “neutral” rating and a $58.00 target price on the stock. Wells Fargo & Company lifted their price target on Doximity from $41.00 to $43.00 and gave the stock an “equal weight” rating in a report on Monday, January 13th. Truist Financial upped their price objective on Doximity from $35.00 to $49.00 and gave the company a “hold” rating in a research note on Thursday, November 14th. Morgan Stanley upgraded Doximity from an “underweight” rating to an “equal weight” rating and lifted their target price for the stock from $33.00 to $53.00 in a research note on Thursday, November 14th. Finally, JPMorgan Chase & Co. increased their price target on shares of Doximity from $30.00 to $48.00 and gave the company a “neutral” rating in a research report on Thursday, November 21st. Thirteen equities research analysts have rated the stock with a hold rating, six have issued a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and an average price target of $53.12.

About Doximity

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.